Previous close | 9.48 |
Open | 9.50 |
Bid | 9.19 x 200 |
Ask | 9.25 x 900 |
Day's range | 9.13 - 9.56 |
52-week range | 9.13 - 14.57 |
Volume | |
Avg. volume | 3,105,088 |
Market cap | 2.805B |
Beta (5Y monthly) | 0.79 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2024 Earnings Call Transcript May 9, 2024 Amicus Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.15985 EPS, expectations were $-0.06. Amicus Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning […]
Comprehensive Analysis of Amicus Therapeutics' First Quarter Financial Performance
Amicus (FOLD) reports first-quarter 2024 results, wherein earnings beat the Zacks Consensus Estimate but sales miss the same. The company updates its financial guidance for 2024.